IGF2BP1 and Miyoshi myopathy: Based on the medians of IGF2BP1 mRNA expression levels, we evaluated the impacts of IGF2BP1 mRNA on overall survival of MM patients with 1q+, del17p, or t(4;14) by Kaplan–Meier survival analysis (log-rank test).